Common Stock Options and Warrants (Details Narrative) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Jun. 30, 2025
USD ($)
$ / shares
shares
|
Mar. 31, 2025
USD ($)
shares
|
Mar. 26, 2025
shares
|
Sep. 30, 2024
$ / shares
shares
|
Apr. 08, 2024 |
Aug. 30, 2023
USD ($)
$ / shares
shares
|
Aug. 15, 2023
USD ($)
a
$ / shares
shares
|
May 03, 2023
USD ($)
$ / shares
shares
|
Aug. 31, 2022
USD ($)
BOED
|
Jun. 30, 2025
USD ($)
$ / shares
shares
|
Mar. 31, 2025
USD ($)
shares
|
Jun. 30, 2024
USD ($)
shares
|
Jun. 30, 2025
USD ($)
$ / shares
shares
|
Jun. 30, 2024
USD ($)
shares
|
Dec. 31, 2024
USD ($)
shares
|
Mar. 24, 2025
USD ($)
|
|
| Non compensatory options to purchase membership interest | 40.00% | |||||||||||||||
| Purchase of non compensatory options | $ | $ 1,000,000 | |||||||||||||||
| Sale of non compensatory options | $ | $ 80,000 | |||||||||||||||
| Restricted options exercisable increments percentage | 25.00% | |||||||||||||||
| Barrels of oil equivalent per day one | BOED | 2,500 | |||||||||||||||
| Barrels of oil equivalent per day two | BOED | 5,000 | |||||||||||||||
| Barrels of oil equivalent per day three | BOED | 7,500 | |||||||||||||||
| Barrels of oil equivalent per day four | BOED | 10,000 | |||||||||||||||
| Non compensatory options acquire | 8,000,000 | |||||||||||||||
| Shares issued price per share | $ / shares | $ 0.25 | |||||||||||||||
| Options are subject to be transferred | 2,000,000 | |||||||||||||||
| Stock issued during period value acquisitions | $ | $ 37,662,000 | |||||||||||||||
| Warrants outstanding | 0 | 0 | 0 | |||||||||||||
| Proceeds from warrant exercises | $ | $ 9,478,000 | |||||||||||||||
| Payments to acquire land held for use | $ | $ 3,000,000.0 | |||||||||||||||
| Warrants exercisable | 0 | 0 | 0 | |||||||||||||
| [custom:LossOnAdjustmentToFairValueEmbeddedDerivativesDebtAndWarrants] | $ | $ (2,373,000) | $ (4,537,000) | ||||||||||||||
| Series F Preferred Stock Warrants [Member] | ||||||||||||||||
| Embedded Derivative, Fair Value of Embedded Derivative Liability | $ | $ 43,700,000 | $ 22,100,000 | 43,700,000 | $ 22,100,000 | $ 43,700,000 | $ 22,100,000 | ||||||||||
| [custom:LossOnAdjustmentToFairValueEmbeddedDerivativesDebtAndWarrants] | $ | $ 21,600,000 | |||||||||||||||
| Subordinated Note Warrants [Member] | ||||||||||||||||
| Warrant issued right to purchase shares | 1,141,552 | 1,141,552 | 1,141,552 | |||||||||||||
| Fair value of the subordinated note warrants | $ | $ 500,000 | $ 500,000 | $ 500,000 | $ 4,200,000 | ||||||||||||
| Initial Genesis [Member] | ||||||||||||||||
| Number of common stock shares | 670,499 | |||||||||||||||
| Area of land | a | 25,240 | |||||||||||||||
| Asset acquisition, price of acquisition, expected | $ | $ 18,000,000.0 | |||||||||||||||
| Initial Genesis [Member] | Exok [Member] | ||||||||||||||||
| Area of land | a | 32,580 | |||||||||||||||
| Genesis Bolton Acquisition [Member] | ||||||||||||||||
| Asset acquisition for total consideration | $ | $ 25,300,000 | |||||||||||||||
| Series D A Warrants [Member] | ||||||||||||||||
| Warrants outstanding | 3,215,761 | 3,215,761 | 3,215,761 | 3,215,761 | ||||||||||||
| Warrants to purchase shares | 0 | 0 | 0 | 0 | ||||||||||||
| Remaining contractual life | 2 years 9 months 18 days | 2 years 9 months 18 days | 2 years 9 months 18 days | 3 years 3 months 18 days | ||||||||||||
| Series D B Warrants [Member] | ||||||||||||||||
| Warrants to purchase shares | 743,610 | 743,610 | ||||||||||||||
| Common Stock exercised for total proceeds | $ | $ 4,500,000 | $ 4,500,000 | ||||||||||||||
| Series E A Warrants [Member] | ||||||||||||||||
| Warrants expire date | Aug. 15, 2028 | Aug. 15, 2028 | Aug. 15, 2028 | |||||||||||||
| Series E B Warrants [Member] | ||||||||||||||||
| Warrants expire date | Aug. 15, 2024 | Aug. 15, 2024 | Aug. 15, 2024 | |||||||||||||
| Merger Options [Member] | ||||||||||||||||
| Remaining contractual life | 9 months 18 days | |||||||||||||||
| Legacy Warrants [Member] | ||||||||||||||||
| Remaining contractual life | 6 months | 6 months | ||||||||||||||
| Warrant issued right to purchase shares | 53,938 | 53,938 | 53,938 | |||||||||||||
| Exercise price | $ / shares | $ 49.71 | |||||||||||||||
| Warrants outstanding | 37,138 | 37,138 | 37,138 | 37,138 | ||||||||||||
| Common Stock [Member] | ||||||||||||||||
| Stock issued during period shares acquisitions | 9,736,904 | 9,736,904 | ||||||||||||||
| Stock issued during period value acquisitions | $ | $ 97,000 | |||||||||||||||
| Warrants exercised issuance of shares | 483,870 | 2,333,334 | ||||||||||||||
| Common Stock [Member] | Series D PIPE Warrants [Member] | ||||||||||||||||
| Warrant issued right to purchase shares | 6,950,500 | 6,950,500 | 6,950,500 | |||||||||||||
| Warrant exercise price | $ / shares | $ 6.00 | $ 6.00 | $ 6.00 | |||||||||||||
| Common Stock [Member] | Series E PIPE Warrants [Member] | ||||||||||||||||
| Warrant issued right to purchase shares | 8,000,000 | 8,000,000 | 8,000,000 | |||||||||||||
| Warrant exercise price | $ / shares | $ 6.00 | $ 6.00 | $ 6.00 | |||||||||||||
| Series E A Warrants [Member] | ||||||||||||||||
| Warrants outstanding | 4,000,000 | 4,000,000 | 4,000,000 | 4,000,000 | ||||||||||||
| Remaining contractual life | 3 years 1 month 6 days | 3 years 1 month 6 days | 3 years 1 month 6 days | 3 years 7 months 6 days | ||||||||||||
| Series E B Warrants [Member] | ||||||||||||||||
| Warrants exercised issuance of shares | 4,000,000 | |||||||||||||||
| Proceeds from warrant exercises | $ | $ 24,000,000.0 | |||||||||||||||
| Exok Warrants [Member] | ||||||||||||||||
| Warrants outstanding | 670,499 | 670,499 | 670,499 | 670,499 | 670,499 | |||||||||||
| Warrant exercise price | $ / shares | $ 7.43 | |||||||||||||||
| Remaining contractual life | 3 years 1 month 6 days | 3 years 1 month 6 days | 3 years 1 month 6 days | 3 years 7 months 6 days | ||||||||||||
| Warrants expire date | Aug. 15, 2028 | |||||||||||||||
| Exok Warrants [Member] | Initial Genesis [Member] | ||||||||||||||||
| Share price | $ / shares | $ 7.43 | |||||||||||||||
| Exok Warrants [Member] | Initial Genesis [Member] | ||||||||||||||||
| Warrants to purchase common stock | 670,499 | |||||||||||||||
| Subordinated Note Warrants [Member] | ||||||||||||||||
| Warrants outstanding | 570,778 | 570,778 | 570,778 | 570,778 | ||||||||||||
| Warrant exercise price | $ / shares | $ 8.89 | $ 8.89 | $ 8.89 | |||||||||||||
| Remaining contractual life | 4 years 3 months 18 days | 4 years 3 months 18 days | 4 years 3 months 18 days | 4 years 9 months 18 days | ||||||||||||
| Subordinated Note Warrants [Member] | Maximum [Member] | ||||||||||||||||
| Warrant, purchase | 1,141,552 | |||||||||||||||
| Noncompensatory Option Purchase Agreement [Member] | ||||||||||||||||
| Shares issued price per share | $ / shares | $ 0.25 | $ 0.25 | ||||||||||||||
| Stock issued during period shares acquisitions | 800,000 | 200,000 | 283,870 | |||||||||||||
| Stock issued during period value acquisitions | $ | $ 2,000 | |||||||||||||||
| Letter Agreement [Member] | Warrant [Member] | ||||||||||||||||
| Beneficial ownership limitation | the holder would own more than 4.99% of the outstanding shares of the Company’s Common Stock, which may be increased by the holder upon written notice to the Company, to any specified percentage not in excess of 9.99% (the “Beneficial Ownership Limitation Ceiling”). The Letter Agreement increases the Beneficial Ownership Limitation Ceiling from 9.99% to 19.99%. Pursuant to the Letter Agreement, Bristol Investment further notified the Company of its intent to immediately increase the Beneficial Ownership Limitation Ceiling to 19.99% and the parties agreed to waive the waiting period with respect to such notice. | |||||||||||||||
| Purchase Agreement [Member] | Series F Preferred Warrants [Member] | ||||||||||||||||
| Sale of stock, description of transaction | the securities purchase agreement with the Series F Preferred Stockholder, upon the one-year anniversary of the issuance date of the Series F Preferred Stock, if any Series F Preferred Stock is outstanding, and the other conditions set forth in the Series F Certificate of Designation have been satisfied, the Company will issue to the Series F Preferred Stock Warrants to the Series F Preferred Stockholder. The Series F Preferred Stock Warrants allow the Series F Preferred Stockholder to purchase a number of shares of the Company’s Common Stock equal to the quotient of (1) 125% of the Stated Value of all Series F Preferred Stock held on the original issuance date of the Series F Preferred Stock (the “Original Issuance Date”), divided by (2) the average of the 10 daily volume-weighted average per share trading prices of the Company’s Common Stock during the 10 trading days prior to the original issuance date | |||||||||||||||
| Bristol Capital LLC [Member] | ||||||||||||||||
| Non compensatory options acquire | $ | 24,000 | |||||||||||||||
| Payments for Repurchase of Common Stock | $ | $ 600,000 | $ 100,000 | ||||||||||||||
| Number of common stock shares | 2,333,334 | |||||||||||||||
| Warrants exercised issuance of shares | 200,000 | |||||||||||||||
| [custom:StockIssuedDuringPeriodSharesRemainingIssuableUponExercise] | 5,366,666 | |||||||||||||||
| BOKA Energy LP [Member] | ||||||||||||||||
| Non compensatory options acquire | $ | $ 8,000 | |||||||||||||||